Clinical Trials Sponsored by AGO Germany

Total 6288 results

Center for Sepsis Control and Care, Germany
German Federal Ministry of Education and Research

Completed

End-of-life Decision-making in Patients With Sepsis-related Organ Failure (EIDECS)

Severe Sepsis

Germany
German Cancer Research Center
University of Heidelberg Medical Center; Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Exercise Intervention Study for Pancreatic Cancer Patients (SUPPORT)

Pancreatic Cancer

Germany
AGO Research GmbH

Not yet recruiting

Pembrolizumab in Combination With Lenvatinib in Patients With Recurrent, Persistent, Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy (PIERCE)

Recurrent Vulvar Cancer | Persistent Vulvar Cancer | Metastatic Vulva Cancer | Locally Advanced Vulvar Cancer
AGO Research GmbH

Recruiting

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (WoO)

Epithelial Ovarian Cancer

Germany
AGO Research GmbH

Completed

Prevalence of BRCA in Patients With Ovarian Cancer

Ovarian Cancer | BRCA Status

Germany
AGO Study Group

Completed

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer

Germany
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
AGO Study Group

Terminated

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

Anemia | Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum | Platinum Sensitve Relapse

Germany
Simone Spuler, MD
German Federal Ministry of Education and Research

Not yet recruiting

Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients (MUST)

Urinary Incontinence | Epispadias, Male

Germany
Center for Sepsis Control and Care, Germany
German Federal Ministry of Education and Research

Completed

Family Satisfaction (FS) in the Intensive Care Unit

Critical Illness

Germany
AIO-Studien-gGmbH
iOMEDICO AG

Terminated

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer (VOXEL)

Colorectal Neoplasms

Germany
Charite University, Berlin, Germany
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study (KOKON-AS)

Breast-cancer

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Colorectal Neoplasms | Hepatocellular Carcinoma | Cholangiocarcinoma

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients (ECONONS)

Malnutrition

Germany
Charite University, Berlin, Germany
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery (PERATECS)

Cancer

Germany
AGO Study Group

Completed

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Germany
AGO Study Group

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube

Germany
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
AGO Study Group

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
AGO Research GmbH

Recruiting

Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer (MIROVA)

Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma

Germany
AGO Study Group

Active, not recruiting

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer (TRUST)

Ovarian Cancer

United States, France, Germany, Austria, Sweden, Denmark, Italy, United Kingdom
AGO Research GmbH

Terminated

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma

Germany
AGO Study Group

Completed

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

Ovarian Diseases | Ovarian Neoplasms | Endometrial Neoplasms | Genital Diseases, Female

Germany
AGO Study Group

Completed

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Ovarian Cancer | Fallopian Tube Cancer

Germany
AGO Study Group

Completed

Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

Epithelial Ovarian Cancer

Germany
AGO Study Group

Completed

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

Ovarian Cancer

Germany
Charite University, Berlin, Germany
Federal Ministry of Health, Germany

Completed

Effects of a Standardized Post-coercion Review Session.

Coercive Measures

Germany
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg; Siemens AG; Bavarian Research Foundation, Munich... and other collaborators

Completed

Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity"

Sarcopenic Obesity
Balgrist University Hospital
Industry (Schülke & Mayr AG, Switzerland and Germany)

Recruiting

General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery (BALGDEC)

Elective Surgery | High Risk | Prevention of Surgical Site Infections | Randomized-controlled Trial

Switzerland
German Breast Group
Roche Pharma AG; Celgene Corporation

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (GeparSepto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
West German Study Group
Sanofi; Roche Pharma AG

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer

Germany
University of Wuerzburg
German Federal Ministry of Education and Research; Deutsche Krebshilfe e.V....

Recruiting

Adrenal Tumors - Pathogenesis and Therapy

Cushing Syndrome | Pheochromocytoma | Adrenocortical Carcinoma | Conn Syndrome | Adrenal Tumors

Germany
University Hospital Schleswig-Holstein
King Systems Corporation; Karl Storz Endoscopy, Germany; LMA, Germany; Venner Medical...

Completed

Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation

Airway Management | Emergency Treatment | Intubation Intratracheal

Germany
Charite University, Berlin, Germany
Senatsverwaltung für Bildung, Wissenschaft und Forschung, Berlin, Germany; KARUNA...

Unknown

Evaluation of a Combined Parent-student Programme for Smoking Prevention in Berlin Schools (BEST)

Tobacco Use Disorder

Germany
University Hospital Muenster
German Federal Ministry of Education and Research; Deutsche Krebshilfe e.V....

Completed

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

Acute Myeloid Leukemia

Germany
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck KGaA, Darmstadt, Germany

Completed

PK Study of Xevinapant (Debio 1143) in Healthy East Asian Participants

Healthy

United Kingdom
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck KGaA, Darmstadt, Germany

Completed

Study Comparing Pharmacokinetics of Different Formulations of Evobrutinib in Healthy Participants

Healthy

United Kingdom
Charite University, Berlin, Germany
University Hospital Tuebingen; Technische Universität Berlin; German Institute...

Recruiting

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins (MOCA)

NAFLD | Type2 Diabetes

Germany
DLR German Aerospace Center
Charite University, Berlin, Germany; University of Erlangen-Nürnberg; University...

Completed

Salty Life 7 Study: Effect of High Salt Intake on Several Physiological Systems in Immobilisation (SL7)

Energy Metabolism | Bone Metabolism | Electrolyte Metabolism | Acid-Base Metabolism | Circulation System

Germany
Charite University, Berlin, Germany
Berlin Institut of Health (BIH), Germany

Active, not recruiting

Optical Coherence Tomography in Acute Coronary Syndrome (OPTICO-ACS)

Acute Coronary Syndrome | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction | Atherosclerosis, Coronary

Germany
Charite University, Berlin, Germany

Recruiting

Patient Survey as a Tool to Quality Assurance and Quality Improvement 2024

Patient Satisfaction

Germany
Charite University, Berlin, Germany

Not yet recruiting

Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid

Heart Failure

Germany
Charite University, Berlin, Germany

Recruiting

Impact of Propionic Acid on Regulatory T Cell Function in Healthy Adults ( Pro-Health) (Pro-Health)

Healthy

Germany
Charite University, Berlin, Germany

Recruiting

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

Glioblastoma

Germany
Charite University, Berlin, Germany

Recruiting

OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia (OXYMIND)

Schizophrenia Spectrum Disorders

Germany
Charite University, Berlin, Germany

Recruiting

Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19

Post-COVID Syndrome

Germany
Charite University, Berlin, Germany

Recruiting

Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer (PRIME)

Cancer

Germany
Charite University, Berlin, Germany

Not yet recruiting

DIGIPREDICT-Physio-DE

Biomarkers
Charite University, Berlin, Germany

Recruiting

Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education. (SEEearly)

Schizophrenia | Schizoaffective Disorder | Acute and Transient Psychotic Disorder, Unspecified | Persistent Delusional Disorder | Other Nonorganic Psychotic Disorders | Unspecified Nonorganic Psychosis

Germany
Charite University, Berlin, Germany

Recruiting

Potential of Moderate Whole Body Hyperthermia to Enhance Response (POWER)

Oncology

Germany

Clinical Trials Sponsored by AGO Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations